Hydrophobic dipeptide Leu-Ile protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis

被引:35
作者
Nitta, A
Nishioka, H
Fukumitsu, H
Furukawa, Y
Sugiura, H
Shen, LY
Furukawa, S
机构
[1] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol, Showa Ku, Nagoya, Aichi 4668560, Japan
[2] Nagoya Univ, Grad Sch Med, Hosp Pharm, Nagoya, Aichi 4668560, Japan
[3] Gifu Pharmaceut Univ, Mol Biol Lab, Gifu, Japan
[4] Gifu Pharmaceut Univ, Lab Exercise Physiol & Hlth Educ, Gifu, Japan
[5] NCI, Cellular Carcinogenesis & Tumor Promot Lab, Ctr Canc Res, Bethesda, MD USA
关键词
immunophilin; glial cell line-derived neurotrophic factor; brain-derived neurotrophic factor; FK506; Leu-Ile; dopamine; mice;
D O I
10.1002/jnr.20258
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We investigated whether certain hydrophobic dipeptides, Leu-Ile, Leu-Pro, and Pro-Ile, which partially resemble the site on FK506 that binds to immunophilin, could stimulate glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF) synthesis in cultured neurons and found only Leu-Ile to be an active dipeptide. Leu-Ile protected against the death of mesencephalic neurons from wild-type mice but not from mice lacking the BDNF or GDNF gene. Next, we examined the effects of i.p. or i.c.v. administration of Leu-Ile on BDNF and GDNF contents. Both types of administration increased the contents of BDNF and GDNF in the striatum of mice. Also, peripheral administration of Leu-Ile inhibited dopaminergic (DA) denervation caused by unilateral injection of 6-hydroxydopamine (6-OHDA) into the striatum of mice. The number of rotations following a methamphetamine challenge was lower in the Leu-Ile-treated group than in the nontreated group. Next, we compared the calcineurin activity and immunosuppressant activity of Leu-Ile with those of FK506. Leu-Ile was not inhibitory toward calcineurin cellular activity in cultured neuronal cells. Furthermore, Leu-Ile did not suppress concanavalin A (ConA)-induced synthesis/ secretion of interleukin-2 by cultured spleen cells, suggesting that the immunosuppressant activity of Leu-Ile may be negligible when used as a therapeutic tool for neurodegenerative diseases. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:250 / 258
页数:9
相关论文
共 50 条
[1]   INTERLEUKIN-4 AND INTERLEUKIN-5 AS MODULATORS OF NERVE GROWTH-FACTOR SYNTHESIS SECRETION IN ASTROCYTES [J].
AWATSUJI, H ;
FURUKAWA, Y ;
HIROTA, M ;
MURAKAMI, Y ;
NII, S ;
FURUKAWA, S ;
HAYASHI, K .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 34 (05) :539-545
[2]   INTERLEUKIN-2 AS A NEUROTROPHIC FACTOR FOR SUPPORTING THE SURVIVAL OF NEURONS CULTURED FROM VARIOUS REGIONS OF FETAL-RAT BRAIN [J].
AWATSUJI, H ;
FURUKAWA, Y ;
NAKAJIMA, M ;
FURUKAWA, S ;
HAYASHI, K .
JOURNAL OF NEUROSCIENCE RESEARCH, 1993, 35 (03) :305-311
[3]   GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR SUPPORTS SURVIVAL OF INJURED MIDBRAIN DOPAMINERGIC-NEURONS [J].
BOWENKAMP, KE ;
HOFFMAN, AF ;
GERHARDT, GA ;
HENRY, MA ;
BIDDLE, PT ;
HOFFER, BJ ;
GRANHOLM, ACE .
JOURNAL OF COMPARATIVE NEUROLOGY, 1995, 355 (04) :479-489
[4]  
Butcher SP, 1997, J NEUROSCI, V17, P6939
[5]   FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain [J].
Cameron, AM ;
Nucifora, FC ;
Fung, ET ;
Livingston, DJ ;
Aldape, RA ;
Ross, CA ;
Snyder, SH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :27582-27588
[6]  
COLLINS F, 1996, NATURE, V380, P252
[7]   Induction of a physiologically active brain-derived neurotrophic factor in the infant rat brain by peripheral administration of 4-methylcatechol [J].
Fukumitsu, H ;
Sometani, A ;
Ohmiya, M ;
Nitta, A ;
Nomoto, H ;
Furukawa, Y ;
Furukawa, S .
NEUROSCIENCE LETTERS, 1999, 274 (02) :115-118
[8]   A HIGHLY SENSITIVE ENZYME-IMMUNOASSAY FOR MOUSE BETA-NERVE GROWTH-FACTOR [J].
FURUKAWA, S ;
KAMO, I ;
FURUKAWA, Y ;
AKAZAWA, S ;
SATOYOSHI, E ;
ITOH, K ;
HAYASHI, K .
JOURNAL OF NEUROCHEMISTRY, 1983, 40 (03) :734-744
[9]   Cyclolinopeptide A (CLA) mediates its immunosuppressive activity through cyclophilin-dependent calcineurin inactivation [J].
Gaymes, TJ ;
Cebrat, M ;
Siemion, IZ ;
Kay, JE .
FEBS LETTERS, 1997, 418 (1-2) :224-227
[10]   MPTP MECHANISMS OF NEUROTOXICITY AND THEIR IMPLICATIONS FOR PARKINSONS-DISEASE [J].
GERLACH, M ;
RIEDERER, P ;
PRZUNTEK, H ;
YOUDIM, MBH .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 208 (04) :273-286